May 23, 2022
Evinacumab phase 3 results show a 48% LDL-C reduction in children with homozygous familial hypercholesterolemia.
May 20, 2022
A look at what the Contemporary Pediatrics® team covered this week.
May 19, 2022
Contemporary Pediatrics® Editorial Advisory Board member Donna Hallas shares her thoughts on the recent authorization of a Pfizer-BioNTech COVID-19 booster shot for children 5-11 years old.
May 17, 2022
Children may receive a single booster shot at least 5 months after completing their initial Pfizer-BioNTech 2-dose series.
April 15, 2022
Pfizer/BioNTech announce positive results for a third dose of their COVID-19 vaccine for children
April 05, 2022
Dr. Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.
March 25, 2022
Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.
February 24, 2022
Editor-in-chief Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, discusses how to help parents who are worried or nervous about the delay in the expansion of the Pfizer/BioNTech vaccine to children aged 6 months to younger than 4 years.
February 14, 2022
The NVX-CoV2373 vaccine was evaluated in adolescents aged 12 to 17 years.
February 10, 2022
The US Food and Drug Administration has given Priority Review to the supplemental Biologics License Application for the use of Dupixent® as an add-on maintenance treatment for moderate-to-severe dermatitis in children aged 6 months to 5 years.